Insmed Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
71.40
-1.62
(-2.22%)
Volume:
1,121,943
52 week range:
21.92 - 80.53
Market Cap:
12.270B
Company Description:
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1.